Home > Official notices > Disciplinary Committee | Search
|
|
Disciplinary CommitteeThe Disciplinary Committee of the Royal Pharmaceutical Society of Great Britain met on Tuesday 27 and Wednesday 28 May 2008 and made the following directions: 1. Following a Statutory Committee inquiry into Sanjay Janubhai
Patel (registration number 76827), the Disciplinary Committee directed the
removal of Mr Patel’s name from the Register. Under Section 11
of the Pharmacy Act 1954, the direction to remove Mr Patel’s name
from the Register is not to take effect until the expiration of a period
of three months from the date on which notice of removal was given or
in a case where an appeal has been brought against the direction, until
the appeal is determined or withdrawn. The Disciplinary Committee will meet at the Royal Pharmaceutical Society of Great Britain, 1 Lambeth High Street, London SE1, on Monday 9, Tuesday 10, Wednesday 11 and Thursday 12 June 2008 at 9.30am to hear the following matters: 1. The Statutory Committee inquiry into a complaint by the Council of
the Society against Melvin Philip Forman (registration number 67021)
which alleges that: during the period between January 1997 and July 2002
Mr Forman endorsed NHS prescriptions for Gaviscon Liquid, Oilatum Emollient,
E45 Cream and Diprobase Cream to indicate that small pack sizes had been
dispensed, when in fact large pack sizes had been dispensed; Mr Forman
caused or permitted the wrongly endorsed prescriptions to be submitted
to the prescription pricing authority (PPA) for payment; as a result
of the submission of wrongly endorsed prescriptions to the PPA, the pharmacies
received and retained overpayments; following an investigation for false
small pack endorsements, the NHS Counter Fraud Security and Management
Service claimed from Mr Forman a repayment of £10,000 in respect
of overpayments referred to above; Mr Forman’s conduct was (a)
dishonest; and/or (b) improper; and/or (c) (since July 2000) contrary
to Key Responsibility 3 of the Code; and/or (d) (since July 2001) contrary
to Part 2 A.2(a) of the Code, and that the particulars of misconduct
alleged above individually or cumulatively may render Mr Forman unfit
to have his name on the Register of Pharmaceutical Chemists. Statutory Committees Secretariat |